To access this data, please log into DSS and submit an application.
Within the application, add this dataset (accession NG00105) in the “Choose a Dataset” section.
Once approved, you will be able to log in and access the data within the DARM portal.

Description

Human post-mortem brain samples were obtained from the Netherlands Brain Bank (NBB) and the Neuropathology Brain Bank and Research CoRE at Mount Sinai Hospital. The permission to collect human brain material was obtained from the Ethical Committee of the VU University Medical Center, Amsterdam, The Netherlands, and the Mount Sinai Institutional Review Board. For the Netherlands Brain bank, informed consent for autopsy, the use of brain tissue and accompanied clinical information for research purposes was obtained per donor ante-mortem.

DNA Genotyping
Samples were genotyped using the Illumina Infinium Global Screening Array (GSA). Genotype imputation was performed for those 90 donors through the Michigan Imputation Server v1.4.1 (Minimac 4) using the 1000 Genomes (Phase 3) v5 (GRCh37) European panel and Eagle v2.4 phasing in quality control and imputation mode with rsq filter set to 0.3. Following imputation, variants were lifted over to the GRCh38 reference to match the RNA-seq data using Picard liftoverVCF and the “b37ToHg38.over.chain.gz” liftover chain file.

RNA extraction and sequencing
RNA was isolated using RNeasy Mini kit (Qiagen) adding the DNase I optional step or as described in detail before (Melief J, et al., 2016). Library preparation was performed at Genewiz using the Ultra-low input system which uses Poly-A selection. SMART-Seq v4 Ultra Low Input RNA Kit was used for library construction using 100 ng of RNA. The libraries were sequenced as 150 bp on fragments with an average read depth of 29 million (ranging from 14-82M) read pairs on the Illumina HiSeq 2500.

RNA-seq data processing
RNA-seq data was processed using the RAPiD pipeline (Wang YC, et al., 2015). RAPiD aligns samples to the hg38 genome build using STAR (Dobin A, et al., 2013) using the GENCODE v30 transcriptome reference and calculates quality control metrics using Picard. RNA-seq quality control was performed applying three filters to remove samples: 1) samples with less than 10M reads aligned from STAR; 2) samples with more than 20% of the reads aligned to ribosomal regions; 3) samples with less than 10% of the reads mapping to coding regions; 4) samples from brain regions with fewer than 20 donors. Estimated transcript abundance was obtained using RSEM (Li B and Dewey CN, 2011) and transcripts were summed to the gene level with tximport (Love MI, et al., 2017). Genes with more than 1 read count per million (CPM) in 30% of the samples were kept for downstream analysis. Gene level read counts were normalized as transcripts per million mapped reads (TPM) to adjust for sequencing library size differences.

Quantitative Trait Loci mapping
To perform expression QTL (eQTL) mapping, we followed the latest pipeline created by the GTEX consortium (Aguet et al. 2019). We completed a separate normalization and filtering method to previous analyses. Gene expression matrices were created from the RSEM output using tximport (Love, Soneson, and Robinson 2017). Matrices were then converted to GCT format, TMM normalized, filtered for lowly expressed genes, removing any gene with less than 0.1 TPM in 20% of samples and at least 6 counts in 20% of samples. Each gene was then inverse-normal transformed across samples. After filtering, we tested a total of 18,430 genes. Then, PEER (Stegle et al. 2012) factors were calculated to estimate hidden confounders within our expression data. We created a combined covariate matrix that included the PEER factors and the first 4 genotyping ancestry MDS values as input to the analysis. We tested numbers of PEER factors from 0 to 20 and found that between 5 and 10 factors produced the largest number of eGenes in each region.
To test for cis-eQTLs, linear regression was performed using the tensorQTL (Taylor-Weiner et al. 2019) cis_nominal mode for each SNP-gene pair using a 1 megabase window within the transcription start site (TSS) of a gene. To test for association between gene expression and the top variant in cis we used tensorQTL cis permutation pass per gene with 1000 permutations. To identify eGenes, we performed q-value correction of the permutation P-values for the top association per gene (Storey 2003) at a threshold of 0.05.
We performed splicing quantitative trait loci (sQTL) analysis using the splice junction read counts generated by regtools (Feng et al. 2018). Junctions were clustered using Leafcutter (Li et al. 2018), specifying for each junction in a cluster a maximum length of 100kb. Following the GTEx pipeline, introns without read counts in at least 50% of samples or with fewer than 10 read counts in at least 10% of samples were removed. Introns with insufficient variability across samples were removed. Filtered counts were then quantile normalized using prepare_phenotype_table.py from Leafcutter, merged, and converted to BED format, using the coordinates from the middle of the intron cluster. We created a combined covariate matrix that included the PEER factors and the first 4 genotyping ancestry MDS values as input to the analysis. We mapped sQTLs with between 0 and 20 PEER factors as covariates in our QTL model and determined 5 to be optimal in MFG, STG and THA. 0 PEER factors were used for SVZ.

To test for cis sQTLs, linear regression was performed using the tensorQTL nominal pass for each SNP-junction pair using a 100kb window from the center of each intron cluster. Although junctions were initially grouped together into clusters, we tested each SNP-junction pair separately, which is the standard approach (Li et al. 2018; Aguet et al. 2019). To test for association between intronic ratio and the top variant in cis we used tensorQTL permutation pass, grouping junctions by their cluster using –grp option. To identify significant clusters, we performed q-value correction using a threshold of 0.05.

Sample Summary per Data Type

Sample SetAccessionData TypeNumber of Samples
MiGA – Microglia Genomic Atlassnd100221000Genomes Imputed GWASn = 90
MiGA – Microglia Genomic Atlassnd10022Bulk RNA Sequencingn = 255

Available Filesets

NameAccessionLatest ReleaseDescription
MiGA – Microglia Genomic Atlas – GWAS Datafsa000008NG00105.v11000Genomes Imputed GWAS
MiGA – Microglia Genomic Atlas – QTL Summary Statisticsfsa000009NG00105.v1QTL Summary Statistics
MiGA – Microglia Genomic Atlas – RNASeq Datafsa000010NG00105.v1RNASeq BAM files

View the File Manifest for a full list of files released in this dataset.

The Microglia Genomic Atlas (MiGA) is a genetic and transcriptomic resource comprised of 255 primary human microglia samples isolated ex vivo from four different brain regions of 100 human subjects with neurodegenerative, neurological, or neuropsychiatric disorders, as well as unaffected controls. We performed systematic analyses to investigate sources of microglial heterogeneity, including brain region, age, and sex. We further performed expression and splicing QTL analyses in each region and performed a meta-analysis across the four regions to increase our discovery power. We then performed colocalization and used fine-mapping and microglia-specific epigenomic data to prioritize genes and variants that influence neurological disease susceptibility through gene expression and splicing in microglia. With this approach, we have built the most comprehensive resource to date of cis genetic effects on the microglial transcriptome and propose underlying molecular mechanisms of potentially causal functional variants in several brain disorders.Human post-mortem brain samples were obtained from the Netherlands Brain Bank (NBB) and the Neuropathology Brain Bank and Research CoRE at Mount Sinai Hospital. The permission to collect human brain material was obtained from the Ethical Committee of the VU University Medical Center, Amsterdam, The Netherlands, and the Mount Sinai Institutional Review Board. For the Netherlands Brain bank, informed consent for autopsy, the use of brain tissue and accompanied clinical information for research purposes was obtained per donor ante-mortem.

Sample SetAccessionNumber of Subjects
MiGA – Microglia Genomic Atlassnd10022n = 108
Consent LevelNumber of Subjects
GRU-IRB-PUBn = 108

Visit the Data Use Limitations page for definitions of the consent levels above.

Acknowledgment statement for any data distributed by NIAGADS:

Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer’s Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689), funded by the National Institute on Aging.

Use the study-specific acknowledgement statements below (as applicable):

For investigators using any data from this dataset:

Please cite/reference the use of NIAGADS data by including the accession NG00105.

For investigators using MiGA (sa000018) data:

We thank members of the Raj and de Witte labs for their feedback on the manuscript. This work was supported by grants from the US National Institutes of Health (NIH NIA R21-AG063130, NIA R01- AG054005, NIA U01-AG068880, and NIA R56-AG055824). This work was supported in part through the computational and data resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD026880. The authors thank Michael Chao for his assistance with genotyping QC. The authors thank the teams of the Netherlands Brain Bank and the Mount Sinai Neuropathology Brain Bank and Research CoRE for their services. We thank the study participants for their generous gifts of brain donation. The microglia were isolated through the efforts of a large team and we would like to thank Manja Litjens, Roland D. van Dijk, Alba Fernández-Andreu, Paul R. Ormel, Hans C. van Mierlo, Y. He, Stephanie Gumbs, Miriam E van Strien, Saskia Burm, Vanessa Donega, and Elly M. Hol for all their contributions to this effort. Gijsje Snijders was supported through ZonMw and the foundation “De Drie Lichten” in the Netherlands. Elisa Navarro was supported by Ramon Areces fellowship.

KATIA DE PAIVA LOPES*, GIJSJE SNIJDERS*, JACK HUMPHREY* et al. “Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies”. bioRxiv, 2020.
Link: https://www.biorxiv.org/content/10.1101/2020.10.27.356113v1